Literature DB >> 5028519

Nature of the defect in congenital factor V deficiency: study in a patient with an acquired circulating anticoagulant.

J C Fratantoni, M Hilgartner, R L Nachman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5028519

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

1.  Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin.

Authors:  T L Ortel; M C Mercer; E H Thames; K D Moore; J H Lawson
Journal:  Ann Surg       Date:  2001-01       Impact factor: 12.969

2.  Isolation and study of an acquired inhibitor of human coagulation factor V.

Authors:  M E Nesheim; W L Nichols; T L Cole; J G Houston; R B Schenk; K G Mann; E J Bowie
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

3.  Rapid elimination of a high-titer spontaneous factor V antibody by extracorporeal antibody-based immunoadsorption and immunosuppression.

Authors:  B Tribl; P Knöbl; K Derfler; S Kapiotis; G Aspöck; U Jäger; W Hörl; K Lechner
Journal:  Ann Hematol       Date:  1995-10       Impact factor: 3.673

4.  Heterogeneity of human factor V deficiency. Evidence for the existence of antigen-positive variants.

Authors:  H C Chiu; E Whitaker; R W Colman
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

5.  Acquired factor V inhibitors after allogeneic hematopoietic stem cell transplantation in a dog.

Authors:  Joseph Masciana; Nathan Peterson; John Chretin
Journal:  J Vet Intern Med       Date:  2020-07-20       Impact factor: 3.333

6.  [Factor V congenital deficiency: about a case].

Authors:  Saloua Boujrad; Brahim El Hasbaoui; Hanae Echahdi; Mohamed Malih; Aomar Agadr
Journal:  Pan Afr Med J       Date:  2017-07-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.